相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells
Amineh Ghaderi et al.
BIOMEDICINES (2020)
Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLC
Sara L. Sinicropi-Yao et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables
Andrew W. Roberts et al.
BLOOD (2019)
Efficacy and Safety of Bcl-2 Inhibitor Venetoclax in Hematological Malignancy: A Systematic Review and Meta-Analysis of Clinical Trials
Qingfang Li et al.
FRONTIERS IN PHARMACOLOGY (2019)
Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody
Suping Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer
Sheau W. Lok et al.
CANCER DISCOVERY (2019)
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Charles M. Rudin et al.
NATURE REVIEWS CANCER (2019)
Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia
Michael Y. Choi et al.
CELL STEM CELL (2018)
Phase I study of immunotherapy for advanced ROR1+malignancies with autologous ROR1-specific chimeric antigen receptor-modified (CAR)-T cells.
Jennifer M. Specht et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells
M. Hojjat-Farsangi et al.
LEUKEMIA (2018)
A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib
Amir Hossein Daneshmanesh et al.
PLOS ONE (2018)
Commonly Occurring Cell Subsets in High-Grade Serous Ovarian Tumors Identified by Single-Cell Mass Cytometry
Veronica D. Gonzalez et al.
CELL REPORTS (2018)
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
L. Horn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
Rajeswara Rao Arasada et al.
NATURE COMMUNICATIONS (2018)
Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression
Timothy L. Lochmann et al.
CLINICAL CANCER RESEARCH (2018)
Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues
Ashwini Balakrishnan et al.
CLINICAL CANCER RESEARCH (2017)
Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer
Jing Shan Lim et al.
NATURE (2017)
MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia
Laura Z. Rassenti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
New insights into stage and prognosis in small cell lung cancer: an analysis of 968 cases
Charles Dayen et al.
JOURNAL OF THORACIC DISEASE (2017)
ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1
Tomoya Yamaguchi et al.
NATURE COMMUNICATIONS (2016)
ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
Yu-Zhu Zheng et al.
SCIENTIFIC REPORTS (2016)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
Pawel K. Mazur et al.
NATURE MEDICINE (2015)
Role of miR-15/16 in CLL
Y. Pekarsky et al.
CELL DEATH AND DIFFERENTIATION (2015)
Clearance of systemic hematologic tumors by venetoclax (Abt-199) and navitoclax
Scott Ackler et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy
Suping Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers
Alexander Augustyn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
ROR1, an embryonic protein with an emerging role in cancer biology
Nicholas Borcherding et al.
PROTEIN & CELL (2014)
Finding the active genes in deep RNA-seq gene expression studies
Traver Hart et al.
BMC GENOMICS (2013)
NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma
Tomoya Yamaguchi et al.
CANCER CELL (2012)
Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
Charles M. Rudin et al.
CLINICAL CANCER RESEARCH (2012)
Comparing antibody and small-molecule therapies for cancer
Kohzoh Imai et al.
NATURE REVIEWS CANCER (2006)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins
RD Ramirez et al.
CANCER RESEARCH (2004)
分享论文
